AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 70 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $860,888 | -9.9% | 369,480 | -8.0% | 0.01% | -7.1% |
| Q2 2023 | $955,560 | +19.8% | 401,496 | -7.4% | 0.01% | +7.7% |
| Q1 2023 | $797,944 | -13.0% | 433,665 | -10.1% | 0.01% | -13.3% |
| Q4 2022 | $917,039 | +19.4% | 482,652 | +34.4% | 0.02% | +7.1% |
| Q3 2022 | $768,000 | -25.7% | 359,110 | -1.7% | 0.01% | -30.0% |
| Q2 2022 | $1,034,000 | – | 365,407 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,300,000 | $17,160,000 | 2.55% |
| Alphabet Inc. | 699,352 | $9,231,000 | 0.56% |
| DAFNA Capital Management LLC | 100,000 | $1,320,000 | 0.45% |
| JUPITER ASSET MANAGEMENT LTD | 705,356 | $9,311,000 | 0.29% |
| Artal Group S.A. | 500,000 | $6,600,000 | 0.26% |
| Cormorant Asset Management, LP | 479,988 | $6,336,000 | 0.25% |
| MPM BioImpact LLC | 39,740 | $525,000 | 0.19% |
| Granahan Investment Management | 305,158 | $4,028,000 | 0.18% |
| Burrage Capital Management LLC | 13,113 | $173,000 | 0.12% |
| Vident Investment Advisory, LLC | 118,866 | $1,569,000 | 0.10% |